These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20964562)

  • 1. A combined biomarker pattern improves the discrimination of lung cancer.
    Liu L; Liu J; Wang Y; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Biomarkers; 2011 Feb; 16(1):20-30. PubMed ID: 20964562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced transthyretin expression in sera of lung cancer.
    Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
    Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
    Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
    Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
    Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
    Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a 17-protein signature in the serum of lung cancer patients.
    Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
    Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
    Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
    Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.
    Le L; Chi K; Tyldesley S; Flibotte S; Diamond DL; Kuzyk MA; Sadar MD
    Clin Chem; 2005 Apr; 51(4):695-707. PubMed ID: 15695329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer.
    Liu DH; Wang XM; Zhang LJ; Dai SW; Liu LY; Liu JF; Wu SS; Yang SY; Fu S; Xiao XY; He DC
    Biomed Environ Sci; 2007 Feb; 20(1):33-40. PubMed ID: 17458139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
    Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
    Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models.
    Vermaat JS; van der Tweel I; Mehra N; Sleijfer S; Haanen JB; Roodhart JM; Engwegen JY; Korse CM; Langenberg MH; Kruit W; Groenewegen G; Giles RH; Schellens JH; Beijnen JH; Voest EE
    Ann Oncol; 2010 Jul; 21(7):1472-1481. PubMed ID: 20022911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.
    de Seny D; Fillet M; Ribbens C; Marée R; Meuwis MA; Lutteri L; Chapelle JP; Wehenkel L; Louis E; Merville MP; Malaise M
    Clin Chem; 2008 Jun; 54(6):1066-75. PubMed ID: 18436720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.